TABLE 3.
Likelihood of different transplant modalities among highly sensitized candidates by era and cPRA category
aSHR | |||
---|---|---|---|
|
|||
Era 2 vs Era 11 | Era 3 vs Era 11 | Era 3 vs Era 21 | |
Overall | |||
DDKT | 0.971.041.12 | 1.74 1.85 1.97 | 1.67 1.77 1.89 |
LDKT | 0.861.001.16 | 0.991.131.30 | 0.991.131.30 |
Non-KPD | 0.65 0.78 0.94 | 0.69 0.82 0.97 | 0.871.041.25 |
KPD | 1.31 1.73 2.29 | 1.70 2.20 2.84 | 1.02 1.27 1.57 |
cPRA | |||
80%-89% | |||
DDKT | 0.941.031.15 | 0.76 0.84 0.92 | 0.73 0.81 0.89 |
LDKT | 0.710.891.11 | 1.05 1.27 1.53 | 1.16 1.43 1.76 |
Non-KPD | 0.54 0.70 0.92 | 0.831.041.31 | 1.14 1.49 1.93 |
KPD | 1.02 1.53 2.29 | 1.41 2.03 2.91 | 0.951.331.85 |
90%-97% | |||
DDKT | 0.951.071.22 | 1.75 1.95 2.17 | 1.64 1.82 2.02 |
LDKT | 0.921.181.52 | 0.981.241.58 | 0.841.051.32 |
Non-KPD | 0.670.921.25 | 0.580.781.07 | 0.620.851.17 |
KPD | 1.25 1.98 3.13 | 1.71 2.62 4.00 | 0.941.321.86 |
98%-99.9% | |||
DDKT | 0.961.201.49 | 5.57 6.62 7.85 | 4.71 5.52 6.48 |
LDKT | 0.801.151.65 | 0.630.911.31 | 0.560.791.13 |
Non-KPD | 0.590.901.39 | 0.37 0.58 0.92 | 0.400.641.03 |
KPD | 1.05 2.21 4.66 | 1.14 2.32 4.73 | 0.611.051.81 |
99.9%+ | |||
DDKT | 0.380.701.31 | 4.23 6.49 9.96 | 5.73 9.24 14.90 |
LDKT | 0.471.313.67 | 0.350.952.59 | 0.300.731.73 |
Non-KPD | 0.361.284.54 | 0.210.772.79 | 0.190.601.85 |
KPD | 0.241.377.99 | 0.271.336.68 | 0.240.973.93 |
Note: Bold indicates P < .05.
Abbreviations: aSHR, adjusted subhazard ratio; cPRA, calculated panel reactive antibody, DDKT, deceased donor kidney transplantation; KPD, kidney-paired donation; LDKT, living donor kidney transplantation.
Reference group.